DB1 ESTIMATING THE LONG-TERM CLINICAL AND ECONOMIC BENEFITS OF INSULIN LISPRO IN TYPE 1 DIABETES IN THE UNITED KINGDOM- A COST-EFFECTIVENESS ANALYSIS BASED ON THE RESULTS OF A RECENT META-ANALYSIS
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66232-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)66232-8/fulltext
Title :
DB1 ESTIMATING THE LONG-TERM CLINICAL AND ECONOMIC BENEFITS OF INSULIN LISPRO IN TYPE 1 DIABETES IN THE UNITED KINGDOM- A COST-EFFECTIVENESS ANALYSIS BASED ON THE RESULTS OF A RECENT META-ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66232-8&doi=10.1016/S1098-3015(10)66232-8
First page :
Section Title :
Open access? :
No
Section Order :
67